The semaglutide cohort ( n = 668) compared with the non-GLP-1RA anti-obesity medications cohort ( n = 21,445) had a higher prevalence of adverse socioeconomic determinants of health, problems related to lifestyle, severe obesity, obesity-associated comorbidities and mental disorders
Ideal candidates are women with documented metabolic dysfunction, insulin resistance, or overweight/obesity alongside endometriosis, where weight management may provide secondary benefit
Losing weight can be challenging
Histological examination showed better granulation tissue formation, improved re-epithelialization, enhanced dermal remodeling, and higher collagen deposition compared to untreated controls
May Be A Good Fit For Guests seeking a quick wellness shot for energy and vitality support